Innovative Fudan rT staging in endoscopic surgery for recurrent nasopharyngeal carcinoma
Background American Joint Committee on Cancer/Union for International Cancer Control (AJCC/UICC) rT staging have great clinical impracticality. The aim of the present study was to establish a new rT staging to guide endoscopic surgery for the treatment of recurrent nasopharyngeal carcinoma (rNPC). M...
Gespeichert in:
| Veröffentlicht in: | Head & neck 2023-02, Vol.45 (2), p.355-364 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 364 |
|---|---|
| container_issue | 2 |
| container_start_page | 355 |
| container_title | Head & neck |
| container_volume | 45 |
| creator | Li, Wanpeng Liu, Qiang Xu, Haoyuan Wang, Huan Zhang, Huangkang Liu, Quan Wang, Jingjing Hu, Li Li, Houyong Sun, Xicai Yu, Hongmeng Wang, Dehui |
| description | Background
American Joint Committee on Cancer/Union for International Cancer Control (AJCC/UICC) rT staging have great clinical impracticality. The aim of the present study was to establish a new rT staging to guide endoscopic surgery for the treatment of recurrent nasopharyngeal carcinoma (rNPC).
Methods
This surgical rT staging (named Fudan rT staging) was constructed using two significant risk factors: the distance from the tumor margin to the internal carotid artery, and dural invasion. Log‐rank and receiver operating characteristic (ROC) curve analyses were used to evaluate its effectiveness.
Results
Fudan rT staging can effectively separate the overall survival (OS) and progression‐free survival (PFS) of patients with rNPC according to the different rT stages (p |
| doi_str_mv | 10.1002/hed.27244 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2737116598</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2737116598</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3534-e96ea91a02744e9834fd71ce4ee76e28e187510840e5780cb827e72d77410bae3</originalsourceid><addsrcrecordid>eNp1kE1LAzEQQIMoflQP_gEJeNHD1snHbnaPUlsrFLwoeFvS7Gxd2SY16Vb6703dehE8ZQiPx8wj5JLBkAHwu3eshlxxKQ_IKYNCJSCkOtzNUiQClDwhZyF8AIDIJD8mJyITOWQFnJK3J2vdRq-bDdJJV2lL_QsNa71o7II2lqKtXDBu1RgaOr9Av6W189Sj6bxHu6ZWB7d6135rF6hbarQ3jXVLfU6Oat0GvNi_A_I6Gb-Mpsns-fFpdD9LjEiFTLDIUBdMA1dSYpELWVeKGZSIKkOeI8tVyiCXgKnKwcxzrlDxSinJYK5RDMhN711599lhWJfLJhhsW23RdaHkSijGsjSqB-T6D_rhOm_jdpFKi4JJBSJStz1lvAvBY12ufLOMB5YMyl3uMuYuf3JH9mpv7ObL-PtL_vaNwF0PfDUtbv83ldPxQ6_8BuwxiKM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2759914703</pqid></control><display><type>article</type><title>Innovative Fudan rT staging in endoscopic surgery for recurrent nasopharyngeal carcinoma</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Li, Wanpeng ; Liu, Qiang ; Xu, Haoyuan ; Wang, Huan ; Zhang, Huangkang ; Liu, Quan ; Wang, Jingjing ; Hu, Li ; Li, Houyong ; Sun, Xicai ; Yu, Hongmeng ; Wang, Dehui</creator><creatorcontrib>Li, Wanpeng ; Liu, Qiang ; Xu, Haoyuan ; Wang, Huan ; Zhang, Huangkang ; Liu, Quan ; Wang, Jingjing ; Hu, Li ; Li, Houyong ; Sun, Xicai ; Yu, Hongmeng ; Wang, Dehui</creatorcontrib><description>Background
American Joint Committee on Cancer/Union for International Cancer Control (AJCC/UICC) rT staging have great clinical impracticality. The aim of the present study was to establish a new rT staging to guide endoscopic surgery for the treatment of recurrent nasopharyngeal carcinoma (rNPC).
Methods
This surgical rT staging (named Fudan rT staging) was constructed using two significant risk factors: the distance from the tumor margin to the internal carotid artery, and dural invasion. Log‐rank and receiver operating characteristic (ROC) curve analyses were used to evaluate its effectiveness.
Results
Fudan rT staging can effectively separate the overall survival (OS) and progression‐free survival (PFS) of patients with rNPC according to the different rT stages (p < 0.05). In addition, ROC analysis showed that the Fudan rT staging exhibited enhanced prognostic value for OS and PFS compared with the AJCC/UICC rT staging.
Conclusions
The innovative Fudan rT staging has a better predictive value for the survival of patients with rNPC than AJCC/UICC rT staging.</description><identifier>ISSN: 1043-3074</identifier><identifier>EISSN: 1097-0347</identifier><identifier>DOI: 10.1002/hed.27244</identifier><identifier>PMID: 36380690</identifier><language>eng</language><publisher>Hoboken, USA: John Wiley & Sons, Inc</publisher><subject>Carotid artery ; Chronic Disease ; endoscopic surgery ; Endoscopy ; Humans ; Nasopharyngeal Carcinoma ; Nasopharyngeal Neoplasms - pathology ; Neoplasm Staging ; Patients ; Prognosis ; Progression-Free Survival ; recurrent ; Retrospective Studies ; Risk factors ; Surgery ; Survival ; T staging ; Throat cancer ; Tumors</subject><ispartof>Head & neck, 2023-02, Vol.45 (2), p.355-364</ispartof><rights>2022 Wiley Periodicals LLC.</rights><rights>2023 Wiley Periodicals LLC.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3534-e96ea91a02744e9834fd71ce4ee76e28e187510840e5780cb827e72d77410bae3</citedby><cites>FETCH-LOGICAL-c3534-e96ea91a02744e9834fd71ce4ee76e28e187510840e5780cb827e72d77410bae3</cites><orcidid>0000-0003-0346-3193 ; 0000-0003-2586-860X ; 0000-0003-1423-0942 ; 0000-0002-2578-9103</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fhed.27244$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fhed.27244$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27903,27904,45553,45554</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36380690$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Li, Wanpeng</creatorcontrib><creatorcontrib>Liu, Qiang</creatorcontrib><creatorcontrib>Xu, Haoyuan</creatorcontrib><creatorcontrib>Wang, Huan</creatorcontrib><creatorcontrib>Zhang, Huangkang</creatorcontrib><creatorcontrib>Liu, Quan</creatorcontrib><creatorcontrib>Wang, Jingjing</creatorcontrib><creatorcontrib>Hu, Li</creatorcontrib><creatorcontrib>Li, Houyong</creatorcontrib><creatorcontrib>Sun, Xicai</creatorcontrib><creatorcontrib>Yu, Hongmeng</creatorcontrib><creatorcontrib>Wang, Dehui</creatorcontrib><title>Innovative Fudan rT staging in endoscopic surgery for recurrent nasopharyngeal carcinoma</title><title>Head & neck</title><addtitle>Head Neck</addtitle><description>Background
American Joint Committee on Cancer/Union for International Cancer Control (AJCC/UICC) rT staging have great clinical impracticality. The aim of the present study was to establish a new rT staging to guide endoscopic surgery for the treatment of recurrent nasopharyngeal carcinoma (rNPC).
Methods
This surgical rT staging (named Fudan rT staging) was constructed using two significant risk factors: the distance from the tumor margin to the internal carotid artery, and dural invasion. Log‐rank and receiver operating characteristic (ROC) curve analyses were used to evaluate its effectiveness.
Results
Fudan rT staging can effectively separate the overall survival (OS) and progression‐free survival (PFS) of patients with rNPC according to the different rT stages (p < 0.05). In addition, ROC analysis showed that the Fudan rT staging exhibited enhanced prognostic value for OS and PFS compared with the AJCC/UICC rT staging.
Conclusions
The innovative Fudan rT staging has a better predictive value for the survival of patients with rNPC than AJCC/UICC rT staging.</description><subject>Carotid artery</subject><subject>Chronic Disease</subject><subject>endoscopic surgery</subject><subject>Endoscopy</subject><subject>Humans</subject><subject>Nasopharyngeal Carcinoma</subject><subject>Nasopharyngeal Neoplasms - pathology</subject><subject>Neoplasm Staging</subject><subject>Patients</subject><subject>Prognosis</subject><subject>Progression-Free Survival</subject><subject>recurrent</subject><subject>Retrospective Studies</subject><subject>Risk factors</subject><subject>Surgery</subject><subject>Survival</subject><subject>T staging</subject><subject>Throat cancer</subject><subject>Tumors</subject><issn>1043-3074</issn><issn>1097-0347</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kE1LAzEQQIMoflQP_gEJeNHD1snHbnaPUlsrFLwoeFvS7Gxd2SY16Vb6703dehE8ZQiPx8wj5JLBkAHwu3eshlxxKQ_IKYNCJSCkOtzNUiQClDwhZyF8AIDIJD8mJyITOWQFnJK3J2vdRq-bDdJJV2lL_QsNa71o7II2lqKtXDBu1RgaOr9Av6W189Sj6bxHu6ZWB7d6135rF6hbarQ3jXVLfU6Oat0GvNi_A_I6Gb-Mpsns-fFpdD9LjEiFTLDIUBdMA1dSYpELWVeKGZSIKkOeI8tVyiCXgKnKwcxzrlDxSinJYK5RDMhN711599lhWJfLJhhsW23RdaHkSijGsjSqB-T6D_rhOm_jdpFKi4JJBSJStz1lvAvBY12ufLOMB5YMyl3uMuYuf3JH9mpv7ObL-PtL_vaNwF0PfDUtbv83ldPxQ6_8BuwxiKM</recordid><startdate>202302</startdate><enddate>202302</enddate><creator>Li, Wanpeng</creator><creator>Liu, Qiang</creator><creator>Xu, Haoyuan</creator><creator>Wang, Huan</creator><creator>Zhang, Huangkang</creator><creator>Liu, Quan</creator><creator>Wang, Jingjing</creator><creator>Hu, Li</creator><creator>Li, Houyong</creator><creator>Sun, Xicai</creator><creator>Yu, Hongmeng</creator><creator>Wang, Dehui</creator><general>John Wiley & Sons, Inc</general><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7TK</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-0346-3193</orcidid><orcidid>https://orcid.org/0000-0003-2586-860X</orcidid><orcidid>https://orcid.org/0000-0003-1423-0942</orcidid><orcidid>https://orcid.org/0000-0002-2578-9103</orcidid></search><sort><creationdate>202302</creationdate><title>Innovative Fudan rT staging in endoscopic surgery for recurrent nasopharyngeal carcinoma</title><author>Li, Wanpeng ; Liu, Qiang ; Xu, Haoyuan ; Wang, Huan ; Zhang, Huangkang ; Liu, Quan ; Wang, Jingjing ; Hu, Li ; Li, Houyong ; Sun, Xicai ; Yu, Hongmeng ; Wang, Dehui</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3534-e96ea91a02744e9834fd71ce4ee76e28e187510840e5780cb827e72d77410bae3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Carotid artery</topic><topic>Chronic Disease</topic><topic>endoscopic surgery</topic><topic>Endoscopy</topic><topic>Humans</topic><topic>Nasopharyngeal Carcinoma</topic><topic>Nasopharyngeal Neoplasms - pathology</topic><topic>Neoplasm Staging</topic><topic>Patients</topic><topic>Prognosis</topic><topic>Progression-Free Survival</topic><topic>recurrent</topic><topic>Retrospective Studies</topic><topic>Risk factors</topic><topic>Surgery</topic><topic>Survival</topic><topic>T staging</topic><topic>Throat cancer</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Li, Wanpeng</creatorcontrib><creatorcontrib>Liu, Qiang</creatorcontrib><creatorcontrib>Xu, Haoyuan</creatorcontrib><creatorcontrib>Wang, Huan</creatorcontrib><creatorcontrib>Zhang, Huangkang</creatorcontrib><creatorcontrib>Liu, Quan</creatorcontrib><creatorcontrib>Wang, Jingjing</creatorcontrib><creatorcontrib>Hu, Li</creatorcontrib><creatorcontrib>Li, Houyong</creatorcontrib><creatorcontrib>Sun, Xicai</creatorcontrib><creatorcontrib>Yu, Hongmeng</creatorcontrib><creatorcontrib>Wang, Dehui</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Head & neck</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Li, Wanpeng</au><au>Liu, Qiang</au><au>Xu, Haoyuan</au><au>Wang, Huan</au><au>Zhang, Huangkang</au><au>Liu, Quan</au><au>Wang, Jingjing</au><au>Hu, Li</au><au>Li, Houyong</au><au>Sun, Xicai</au><au>Yu, Hongmeng</au><au>Wang, Dehui</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Innovative Fudan rT staging in endoscopic surgery for recurrent nasopharyngeal carcinoma</atitle><jtitle>Head & neck</jtitle><addtitle>Head Neck</addtitle><date>2023-02</date><risdate>2023</risdate><volume>45</volume><issue>2</issue><spage>355</spage><epage>364</epage><pages>355-364</pages><issn>1043-3074</issn><eissn>1097-0347</eissn><abstract>Background
American Joint Committee on Cancer/Union for International Cancer Control (AJCC/UICC) rT staging have great clinical impracticality. The aim of the present study was to establish a new rT staging to guide endoscopic surgery for the treatment of recurrent nasopharyngeal carcinoma (rNPC).
Methods
This surgical rT staging (named Fudan rT staging) was constructed using two significant risk factors: the distance from the tumor margin to the internal carotid artery, and dural invasion. Log‐rank and receiver operating characteristic (ROC) curve analyses were used to evaluate its effectiveness.
Results
Fudan rT staging can effectively separate the overall survival (OS) and progression‐free survival (PFS) of patients with rNPC according to the different rT stages (p < 0.05). In addition, ROC analysis showed that the Fudan rT staging exhibited enhanced prognostic value for OS and PFS compared with the AJCC/UICC rT staging.
Conclusions
The innovative Fudan rT staging has a better predictive value for the survival of patients with rNPC than AJCC/UICC rT staging.</abstract><cop>Hoboken, USA</cop><pub>John Wiley & Sons, Inc</pub><pmid>36380690</pmid><doi>10.1002/hed.27244</doi><tpages>10</tpages><orcidid>https://orcid.org/0000-0003-0346-3193</orcidid><orcidid>https://orcid.org/0000-0003-2586-860X</orcidid><orcidid>https://orcid.org/0000-0003-1423-0942</orcidid><orcidid>https://orcid.org/0000-0002-2578-9103</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1043-3074 |
| ispartof | Head & neck, 2023-02, Vol.45 (2), p.355-364 |
| issn | 1043-3074 1097-0347 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2737116598 |
| source | MEDLINE; Wiley Online Library Journals Frontfile Complete |
| subjects | Carotid artery Chronic Disease endoscopic surgery Endoscopy Humans Nasopharyngeal Carcinoma Nasopharyngeal Neoplasms - pathology Neoplasm Staging Patients Prognosis Progression-Free Survival recurrent Retrospective Studies Risk factors Surgery Survival T staging Throat cancer Tumors |
| title | Innovative Fudan rT staging in endoscopic surgery for recurrent nasopharyngeal carcinoma |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T13%3A34%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Innovative%20Fudan%20rT%20staging%20in%20endoscopic%20surgery%20for%20recurrent%20nasopharyngeal%20carcinoma&rft.jtitle=Head%20&%20neck&rft.au=Li,%20Wanpeng&rft.date=2023-02&rft.volume=45&rft.issue=2&rft.spage=355&rft.epage=364&rft.pages=355-364&rft.issn=1043-3074&rft.eissn=1097-0347&rft_id=info:doi/10.1002/hed.27244&rft_dat=%3Cproquest_cross%3E2737116598%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2759914703&rft_id=info:pmid/36380690&rfr_iscdi=true |